BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 8791128)

  • 21. Cell senescence and cancer.
    Mathon NF; Lloyd AC
    Nat Rev Cancer; 2001 Dec; 1(3):203-13. PubMed ID: 11902575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The roles of telomeres and telomerase in cellular immortalization and the development of cancer.
    Klingelhutz AJ
    Anticancer Res; 1999; 19(6A):4823-30. PubMed ID: 10697595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of telomere-binding proteins in carcinogenesis].
    Aragona M; Pontoriero A; Panetta S; La Torre I; La Torre F
    Minerva Med; 2000; 91(11-12):299-304. PubMed ID: 11253711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase as a therapeutic target. Therapeutic potential of telomerase inhibitors.
    Double JA
    Methods Mol Biol; 2002; 191():209-16. PubMed ID: 11951608
    [No Abstract]   [Full Text] [Related]  

  • 25. Ageing and cancer: the telomere and telomerase connection.
    Shay JW; Wright WE
    Novartis Found Symp; 2001; 235():116-25; discussion 125-9, 146-9. PubMed ID: 11280022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Telomerase: an enzyme with multiple applications in cancer research].
    Castillo Ureta H; Barrera Saldaña HA; Martínez Rodríguez HG
    Rev Invest Clin; 2002; 54(4):342-8. PubMed ID: 12415959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomerase, checkpoints and cancer.
    Harley CB; Sherwood SW
    Cancer Surv; 1997; 29():263-84. PubMed ID: 9338104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telomere length mediates the effects of telomerase on the cellular response to genotoxic stress.
    Rubio MA; Davalos AR; Campisi J
    Exp Cell Res; 2004 Aug; 298(1):17-27. PubMed ID: 15242758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomere--the twilight to immortality.
    Shukla S; Acharya S; Rajput D; Vagha S; Grover S
    J Assoc Physicians India; 2010 Sep; 58():553-60. PubMed ID: 21391375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telomere crisis, the driving force in cancer cell evolution.
    Ishikawa F
    Biochem Biophys Res Commun; 1997 Jan; 230(1):1-6. PubMed ID: 9020020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
    Raymond E; Faivre S; Dieras V; Von Hoff D
    Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase: regulation, function and transformation.
    Dong CK; Masutomi K; Hahn WC
    Crit Rev Oncol Hematol; 2005 May; 54(2):85-93. PubMed ID: 15843091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of telomerase activity and telomere length.
    Wu KD; Moore MA
    Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomerase as a clinical target: current strategies and potential applications.
    Fleisig HB; Wong JM
    Exp Gerontol; 2007; 42(1-2):102-12. PubMed ID: 16814507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process.
    Ducray C; Pommier JP; Martins L; Boussin FD; Sabatier L
    Oncogene; 1999 Jul; 18(29):4211-23. PubMed ID: 10435634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase and human tumorigenesis.
    Stewart SA; Weinberg RA
    Semin Cancer Biol; 2000 Dec; 10(6):399-406. PubMed ID: 11170862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase: cellular immortalization and neoplastic transformation. Multiple functions of a multifaceted complex.
    Belgiovine C; Chiodi I; Mondello C
    Cytogenet Genome Res; 2008; 122(3-4):255-62. PubMed ID: 19188694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
    Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
    Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomerase as an anti-cancer drug target: will it fulfil its early promise?
    Newbold RF
    Anticancer Drug Des; 1999 Aug; 14(4):349-54. PubMed ID: 10625927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.